Delivery Order SPE2DB22D6029-SPE2DB25FLSUP

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,376.42 firm fixed-price delivery order is for the supply of 88 ml vials of 50 mg/ml valganciclovir HCl, a medication used in the treatment of viral infections. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,507.63, is for the delivery of 60 tablets of the medication Valganciclovir 450 mg. The contract has a firm fixed price and an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a firm fixed price delivery order with a ceiling value of $1,111.53 for the supply of valganciclovir hydrochloride 50 mg/mL oral solution. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to support military treatment programs and facilities. The delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,948.63 firm fixed-price delivery order is for the supply of 4558106928 valganciclovir HCL 50 mg/ml medication. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 15, 2022. No set-aside was used for this open competition contract. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,941.22 Firm Fixed Price delivery order is for the supply of 60 tablets of 450 mg Valganciclovir, a medication used to treat cytomegalovirus infections. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valganciclovir 450 mg tablets. The fixed-price contract has a ceiling value of $1,559.32 and a completion date of February 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,668.46 and is for the delivery of valganciclovir 450 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 15, 2023. This award is not designated as a set-aside contract. AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 60 count bottles of 450 mg valganciclovir tablets. This $2,050.03 award has an ultimate completion date of April 12, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and provides a wide range of pharmaceutical products and medical...
This is a $2,458.82 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567117522 valganciclovir HCL 50 mg/ml 88ml, a specialty medication. The award date is January 31, 2025, with a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This federal contract award is a delivery order (SPE2DB22D3004|SPE2DB25FPH63) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,055.37 firm fixed-price contract is for the supply of valganciclovir HCL 50 mg/ml, an antiviral medication, to support military healthcare programs. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLSUP
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,902.03 firm-fixed-price delivery order is for the supply of 88 ml of valganciclovir hydrochloride 50 mg/ml, a medication used to treat cytomegalovirus infections. The contract has an ultimate completion date of October 18, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This delivery order does not have a set-aside designation, indicating open competition.

Generated 1/16/25, 9:08 AM